Nasal Steam Therapy for Post-extubation Respiratory Events

Sponsor
Ilsan Cha hospital
Study ID
NCT06840106
Status
Recruiting
Apply to this trial

Conditions

  • Intubation
  • Thyroid Cancer

Eligibility Criteria

Sex
ALL
Age
19 Years - 69 Years
Healthy Volunteers
Not accepted

Interventions

  • Nasal steam therapy — PROCEDURE
    Nasal steam therapy is performed once a every other day for a total of 3three times. The steam inhalation stimulates the acupoints of bilateral LI20, EX-HN8, and EX-HN9
  • Routine management strategy — PROCEDURE
    Depending on the patient's symptoms and degree of improvement, the clinician may utilize all drugs currently used in clinical practice to improve upper respiratory symptoms, if necessary. All drugs that fall under the Anatomical Therapeutic Chemical Classification System (ATC) codes of non-disease treatment (R01), throat disease treatment (R02), lung disease or expectorant (R03, R05), and other respiratory organ drugs (R06, R07) and other drugs. The usage and dosage should be within the range of the current clinical guidelines.

Study Details

The effect of symptom improvement of nasal steam strategy compared to routine management strategy for upper respiratory symptoms occurring after endotracheal intubation in patients aged 19 years or older who underwent surgical removal under anesthesia requiring endotracheal intubation was evaluated by the difference in the results of Wisconsin Upper Respiratory Symptom Survey

Key Dates

First listed
Feb 21, 2025
Start date
Feb 18, 2025
Status verified
Mar 2025
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
66 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Nasal Steam therapy strategy
    Nasal steam therapy is performed once a every other day for a total of 3three times. The steam inhalation stimulates the acupoints of bilateral LI20, EX-HN8, and EX-HN9
  • Active Comparator: Routine management strategy
    This study is a practical clinical study, and the selection of drugs and other treatment methods will be based on the doctor's clinical judgment regarding the patient's symptoms, degree of improvement, etc. Drug administration or patient education will be implemented according to symptoms. Depending on the patient's symptoms and degree of improvement, the clinician may utilize all drugs currently used in clinical practice to improve upper respiratory symptoms, if necessary. All drugs that fall under the Anatomical Therapeutic Chemical Classification System (ATC) codes of non-disease treatment (R01), throat disease treatment (R02), lung disease or expectorant (R03, R05), and other respiratory organ drugs (R06, R07) and other drugs that clinicians orally administer in current clinical practice for the purpose of improving upper respiratory symptoms will be collected.

Primary Outcome Measure

Wisconsin upper respiratory symptom survey-24, WURSS-24 [ Time Frame: From enrollment to the end of treatment at Day 8, and follow up visit at Day 15 ]

Central Contacts

Related Studies